It is certain that the content of S100A8, S100A9, and S100A12 proteins in serum or fecal are closely related to diseases and can be used as biomarkers for their detection and diagnosis, including rheumatoid arthritis (RA), inflammatory bowel disease (IBD), cancer, etc. [7,8,9]. This evidence concerns the gene S100A8 and irritable bowel syndrome.